Ocular Findings Before and After Pegylated Interferon Treatment in Chronic Hepatitis B and C Patients

Creative Commons License

Kose Ş., Turken M., Kuzucu L., Ture G., Orsel T.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.20, no.1, pp.1-3, 2014 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 1
  • Publication Date: 2014
  • Doi Number: 10.4274/vhd.35229
  • Journal Name: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1-3
  • Keywords: Hepatit B, hepatit C, pegile-interferon-alfa, retinopati
  • Dokuz Eylül University Affiliated: No

Abstract

Objective: Interferons are used in the treatments of chronic hepatitis B and C since they inhibit viral replication and have immunomodulatory effects. Common side effects include: flu-like syndrome, hematologic abnormalities, cardiovascular system and gastrointestinal system symptoms, diabetes, autoimmune disorders, pulmonary dysfunction, and suffering from depression. In this study, the development of retinopathy, a rare side effect of interferon, was aimed to be investigated.